Sample size calculation for stepped wedge and other longitudinal cluster randomised trials by Hooper, R et al.
1 
 
Sample size calculation for stepped wedge and other longitudinal cluster randomised 
trials 
 
Richard Hooper,a Steven Teerenstra,b Esther de Hoop,c Sandra Eldridgea 
 
a Centre for Primary Care & Public Health, Queen Mary University of London, London, UK 
 
b Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, 
Netherlands 
 
c Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, 
Utrecht, Netherlands 
 
 
Address for correspondence: 
 
Dr Richard Hooper, 
Centre for Primary Care & Public Health, 
Yvonne Carter Building, 
58 Turner Street, 
London E1 2AB, 
UK 
 
phone: 020 7882 7324 
fax: 020 7882 2552 
email: r.l.hooper@qmul.ac.uk 
 
 
 
Word count: 4209 (manuscript) + 213 (abstract) 
  
2 
 
Abstract 
 
The sample size required for a cluster randomised trial is inflated compared to an individually 
randomised trial because outcomes of participants from the same cluster are correlated. 
Sample size calculations for longitudinal cluster randomised trials (including stepped wedge 
trials) need to take account of at least two levels of clustering: the clusters themselves, and 
times within clusters. We derive formulae for sample size for repeated cross-section and 
closed cohort cluster randomised trials with normally distributed outcome measures, under a 
multi-level model allowing for variation between clusters and between times within clusters. 
Our formulae agree with those previously described for special cases such as cross-over and 
ANCOVA design, though simulation suggests that the formulae could underestimate required 
sample size when the number of clusters is small. Whether using a formula or simulation, a 
sample size calculation requires estimates of nuisance parameters, which in our model 
include the intracluster correlation, cluster autocorrelation and individual autocorrelation. A 
cluster autocorrelation less than 1 reflects a situation where individuals sampled from the 
same cluster at different times have less correlated outcomes than individuals sampled from 
the same cluster at the same time. Nuisance parameters could be estimated from time series 
obtained in similarly clustered settings with the same outcome measure, using analysis of 
variance to estimate variance components.  
 
Keywords: clinical trial design, cluster randomized trial, intracluster correlation, sample size, 
stepped wedge 
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1. Introduction 
 
Cluster randomised trials take as their unit of randomisation a cluster or collective of 
individual participants [1]. This is typically for pragmatic reasons: the intervention might be 
delivered at cluster level, for example, or there might otherwise be a risk of contamination 
between treatments delivered to participants in the same cluster. The sample size required for 
a cluster randomised trial is inflated compared to an individually randomised trial because 
outcomes of participants from the same cluster are correlated [2]. A number of articles [3–9] 
have discussed the calculation of sample size for cluster randomised clinical trials in which 
two or more independent cross sections are taken from each cluster at given time intervals, 
with all the participants at any given time in any given cluster receiving either the 
experimental or the control treatment. The analysis of such a trial should ideally take account 
of two levels of clustering: the clusters themselves and the cross-sections within clusters. 
Sample size calculations assuming this kind of hierarchical multi-level model have been 
described for a general family of repeated cross-section designs including parallel group and 
stepped wedge designs [8]. 
 
Stepped wedge designs randomise clusters to trial arms with varying delays in switching 
from the control to the experimental intervention [10–12] – see Figure 1 for an example. 
There is growing interest in the use of stepped wedge trials to evaluate service delivery and 
other health interventions delivered at an organisational or institutional level, particularly 
when a policy decision to implement the intervention across a number of clusters has already 
been made [7, 13]. In such cases stepped wedge designs have a practical advantage over 
parallel group designs when there are only sufficient resources to “switch on” the 
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intervention in a small number of clusters at any given time [10, 11, 14], and they may also 
have a statistical power advantage [6, 15, 16].  
 
Longitudinal cluster randomised trials need not involve taking repeated cross-sections. A 
recent review [17] has described a broad typology of stepped wedge designs, differentiated 
according to how individuals are exposed, whether the same individuals are exposed to both 
the control and the intervention, and how outcome measurements are obtained. One 
alternative to a repeated cross-section design is a closed cohort design in which participants 
are all identified at the start of the trial and then followed over time. No general approach to 
calculating sample size for a closed cohort cluster randomised trial has been described in the 
literature [7, 9], though Girling & Hemming, in their study of relative efficiency and optimal 
design [18], have demonstrated the common ground between closed cohort and repeated 
cross-section designs, building on work done in the special case of the ANCOVA design (a 
parallel group design with a single baseline and single follow-up assessment) [5]. In this 
article we establish a common framework for sample size calculations for longitudinal 
designs which includes a number of previously published results as special cases. 
 
In Section 2 we review the process of sample size calculation for a repeated cross-section 
cluster randomised trial, which has been described elsewhere [8], and in Section 3 we show 
how to adapt this calculation to the closed cohort situation. In Section 4 we present an 
example of a sample size calculation for a closed cohort cluster randomised trial, using our 
derived formula and using simulation. Finally in Section 5 we discuss our findings and some 
suggestions for further work. 
 
2. Repeated cross-section cluster randomised trials 
5 
 
 
2.1. Statistical model 
 
We consider a continuous, normally distributed outcome measure. To keep things simple we 
assume the same number of individuals is sampled in each cross-section of each cluster. In 
addition, all the designs considered in this article will have the same number of clusters 
randomised to each arm of the trial. We assume cross-sections are taken within clusters at 
predefined, discrete times following randomisation. Note this is qualitatively different to a 
design involving continuous recruitment of participants over time [17], in which the sample 
size at each step would depend on its duration and the rate of recruitment.   
 
Suppose, then, that in each of L trial arms l=1,…,L there are K clusters k=1,…,K, each of 
which has cross-sections taken at times t=0,1,2,…T after randomisation, with each cross-
section consisting of m individuals, i=1,…,m. We assume a model in which the outcome for 
individual i at time t in cluster k, arm l is 
 
 𝑌𝑖𝑡𝑘𝑙 = 𝛾 + 𝜃𝑡 + 𝐴𝑙𝑡𝛿 + 𝜉𝑘𝑙 + 𝜂𝑡𝑘𝑙 + 𝜀𝑖𝑡𝑘𝑙, (1) 
 
where 𝜀𝑖𝑡𝑘𝑙~N(0, 𝜎error
2 ) 
𝜂𝑡𝑘𝑙~N(0, 𝜎time|clust
2 ) 
𝜉𝑘𝑙~N(0, 𝜎clust
2 ), 
 
with the 𝜀𝑖𝑡𝑘𝑙, 𝜂𝑡𝑘𝑙 and 𝜉𝑘𝑙 all independent of one another, and 
 
𝐴𝑙𝑡 = {
1 if arm 𝑙 is receiving the experimental treatment at time 𝑡
0 if arm 𝑙 is receiving the control treatment at time 𝑡.         
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This hierarchical multi-level model includes random effects which model variation between 
clusters (𝜉𝑘𝑙) and also variation between times within a cluster (𝜂𝑡𝑘𝑙). The parameter  is the 
treatment effect, which we assume is maintained once the intervention has been introduced. 
The model also includes a fixed effect of time, 𝜃𝑡, which must be estimated independently of 
the treatment effect so that a systematic change over time is not mistaken for an effect of 
treatment. For identifiability we set 𝜃0=0. Note that in cluster randomised trials with a 
stepped wedge design it is quite usual for all the clusters to be randomised simultaneously, so 
that an effect of time since randomisation is the same as an effect of calendar time – an 
equivalence rarely found in individually randomised trials [19]. 
 
It will be convenient to transform the nuisance parameters 𝜎error
2 , 𝜎time|clust
2  and 𝜎clust
2  into 
three new parameters 
 
𝜎2 = 𝜎error
2 + 𝜎time|clust
2 + 𝜎clust
2  
 
𝜌 = (𝜎time|clust
2 + 𝜎clust
2 ) (𝜎error
2 + 𝜎time|clust
2 + 𝜎clust
2 )⁄  
 
𝜋 = 𝜎clust
2 (𝜎time|clust
2 + 𝜎clust
2 )⁄  
 
where σ2 is the total variance and  is the intra-cluster correlation – i.e. the correlation 
between assessments of two individuals sampled from the same cluster at the same time. The 
interpretation of  is discussed below. 
 
2.2. Sample size calculation 
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We use the following notation for different settings: SI = Single cross-section, Individually 
randomised; SC = Single cross-section, Cluster randomised; RC = Repeated cross-section, 
Cluster randomised; CI = Closed cohort, Individually randomised; CC = Closed cohort, 
Cluster randomised. 
 
We define 𝑛SI to be the total sample size required to detect treatment effect 𝛿
∗ with power 
1 − 𝛽 at two-sided significance level α, by comparing two independent groups of equal size, 
randomised at the individual level and assessed once. 𝑛SI can be calculated using the 
approximate formula [20]: 
 
 𝑛SI = 4(
𝜎
𝛿∗
)
2
(𝑧1−𝛼/2 + 𝑧1−𝛽)
2
 (2) 
 
where 𝑧𝑝 is the 100pth centile of a standard normal distribution. Alternatively this sample 
size can be obtained from standard tables or software. 
 
Using a single cross-section cluster randomised (SC) design the total number of clusters 
required, allowing for the clustering [2], becomes 
 
𝑁SC = DeffC(𝑚, 𝜌) ×
𝑛SI
𝑚
 
 
where DeffC is the design effect due to cluster randomising 
 
 DeffC(𝑚, 𝜌) = 1 + (𝑚 − 1)𝜌. (3) 
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If the same clusters are assessed in repeated cross sections then fewer clusters are required to 
achieve the same power. The efficiency of a repeated cross-section design under model (1) 
can be determined by finding the linear unbiased estimator for the treatment effect that has 
smallest variance. Formulae for sample size have been derived elsewhere [8]. The total 
number of clusters required is 
 
 𝑁RC = DeffR(𝑟RC) × DeffC(𝑚, 𝜌) ×
𝑛SI
𝑚
 (4) 
 
where 𝑟RC is the correlation between two sample means of m participants from the same 
cluster in different cross-sections 
 
 𝑟RC =
𝑚𝜌𝜋
1 + (𝑚 − 1)𝜌
 (5) 
  
and DeffR(𝑟) is the design effect due to repeated assessment for correlation r 
 
DeffR(𝑟) =
𝐿2(1 − 𝑟)(1 + 𝑇𝑟)
4(𝐿𝐵 − 𝐷 + (𝐵2 + 𝐿𝑇𝐵 − 𝑇𝐷 − 𝐿𝐶)𝑟)
 
 
with constants B,C and D defined from matrix A in (1) 
 
𝐵 = Σ𝑡𝑙𝐴𝑙𝑡,   𝐶 = Σ𝑙(Σ𝑡𝐴𝑙𝑡)
2,  𝐷 = Σ𝑡(Σ𝑙𝐴𝑙𝑡)
2. 
 
Each cluster has 𝑚(𝑇 + 1) participants; hence the total number of participants required for a 
repeated cross-section cluster randomised trial is 
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 𝑛RC = DeffR(𝑟RC) × DeffC(𝑚, 𝜌) × (𝑇 + 1)𝑛SI. (6) 
 
In (5) the parameter  is the limit of 𝑟RC as 𝑚𝜌 → ∞, and can thus be interpreted as the 
correlation between two population means from the same cluster at different times. We refer 
to  as the cluster autocorrelation [5]. 
 
Consider, for example, a stepped wedge design of the form shown in Figure 1, but with an 
arbitrary number of steps L. In this case T = L and matrix A is given by 
 
𝐀 =
(
 
 
0 1 1
0 0 1
0 0 0
⋯
⋯
⋯
1 1
1 1
1 1
⋮ ⋮ ⋮ ⋮ ⋮
0 0 0 … 0 1)
 
 
. 
 
The design effect due to repeated assessment is then 
 
 DeffR,L-step(𝑟) =
3𝐿(1 − 𝑟)(1 + 𝐿𝑟)
(𝐿2 − 1)(2 + 𝐿𝑟)
 (7) 
 
and the total required sample size becomes 
 
 𝑛RC,L-step =
3𝐿(1 − 𝑟RC)(1 + 𝐿𝑟RC)
(𝐿 − 1)(2 + 𝐿𝑟RC)
(1 + (𝑚 − 1)𝜌)𝑛SI. (8) 
 
 
2.3. Related sample size formulae 
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The general formula (6) includes some previously described formulae as special cases. 
Consider, for example, a cross-over design with L = 2, T = 1, and matrix A given by 
 
𝐀 = (
1 0
0 1
). 
 
Then the design effect due to repeated assessment becomes 
 
DeffR,cross(𝑟) =
1 − 𝑟
2
 
 
and the total required sample size becomes 
 
𝑛RC,cross = (1 + (𝑚 − 1)𝜌 − 𝑚𝜌𝜋)𝑛SI 
 
which reproduces the formula of Giraudeau and colleagues [4] for a repeated cross-section 
cluster randomised cross-over trial. 
 
Alternatively, consider the ANCOVA design, with L = 2, T = 1, and matrix A given by 
 
𝐀 = (
0 0
0 1
). 
 
In this case the design effect due to repeated assessment becomes 
 
DeffR,ANCOVA(𝑟) = 1 − 𝑟
2 
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and the total required sample size becomes 
 
𝑛RC,ANCOVA = 2(1 − 𝑟RC
2 )(1 + (𝑚 − 1)𝜌)𝑛SI 
 
which is equivalent to the formula of Teerenstra and colleagues [5] for a repeated cross-
section cluster randomised trial with an ANCOVA design. 
 
If we make the simplifying assumption in model (1) that 𝜎time|clust
2 = 0 (or equivalently that 
𝜋 = 1), then equation (6) reduces to the sample size formula of Hussey & Hughes [3], and 
(8) reduces to the formula of Woertman and colleagues [6] for a stepped wedge design. This 
simplified model with 𝜋 = 1 is also the one assumed in Hemming and colleagues’ 
“steppedwedge” sample size procedure in Stata [21]. 
 
3. Closed cohort cluster randomised trials 
 
3.1. Statistical model 
 
In a closed cohort cluster randomised trial we follow the same participants over time rather 
than taking a fresh cross-section from each cluster at each time. We assume that the 
participants in a given cluster are all identified at the beginning of the trial and assessed at a 
series of predefined, discrete times following randomisation. For any given assessment all 
participants from a given cluster are exposed either to the experimental or the control 
treatment. In a closed cohort design we need to allow for dependence between outcomes 
assessed in the same participant over time. The simplest way to model this is to assume an 
12 
 
additional random effect of participant [7]. Thus we assume a model in which the outcome at 
time t=0,…,T for individual i=1,…,m in cluster k=1,…,K, arm l=1,…,L is 
 
 𝑌𝑖𝑡𝑘𝑙 = 𝛾 + 𝜃𝑡 + 𝐴𝑙𝑡𝛿 + 𝜉𝑘𝑙 + 𝜁𝑖𝑘𝑙 + 𝜂𝑡𝑘𝑙 + 𝜀𝑖𝑡𝑘𝑙, (9) 
 
where 𝜀𝑖𝑡𝑘𝑙~N(0, 𝜎error
2 ) 
𝜁𝑖𝑘𝑙~N(0, 𝜎indiv|clust
2 ) 
𝜂𝑡𝑘𝑙~N(0, 𝜎time|clust
2 ) 
𝜉𝑘𝑙~N(0, 𝜎clust
2 ), 
 
with the 𝜀𝑖𝑡𝑘𝑙, 𝜂𝑡𝑘𝑙 , 𝜁𝑖𝑘𝑙 and 𝜉𝑘𝑙 all independent of one another, and 
 
𝐴𝑙𝑡 = {
1 if arm 𝑙 is receiving the experimental treatment at time 𝑡
0 if arm 𝑙 is receiving the control treatment at time 𝑡.         
 
 
This is no longer a hierarchical model: individuals are not nested within times, nor times 
within individuals – instead each individual is assessed at each time, and there is a random 
effect of individual within cluster, 𝜁𝑖𝑘𝑙, and a random effect of time within cluster, 𝜂𝑡𝑘𝑙. This 
is an example of a cross-classified multi-level model [22]. The random effect of time within 
cluster might be the result of changes to the way in which treatment is delivered at a given 
cluster over time, and represents a kind of interaction between time and cluster. 
 
We define 
 
𝜎2 = 𝜎error
2 + 𝜎indiv|clust
2 + 𝜎time|clust
2 + 𝜎clust
2  
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𝜌 = (𝜎time|clust
2 + 𝜎clust
2 ) (𝜎error
2 + 𝜎indiv|clust
2 + 𝜎time|clust
2 + 𝜎clust
2 )⁄  
 
𝜋 = 𝜎clust
2 (𝜎time|clust
2 + 𝜎clust
2 )⁄  
 
𝜏 = 𝜎indiv|clust
2 (𝜎error
2 + 𝜎indiv|clust
2 )⁄  
 
where, as in model (1), σ2 is the total variance,  is the intracluster correlation (the correlation 
between assessments of two individuals from the same cluster at the same time) and  is the 
cluster autocorrelation (the correlation between two population means from the same cluster 
at different times).  is the correlation between two assessments of the same individual at 
different times in a given cluster, or the individual autocorrelation [5]. 
 
3.2. Sample size calculation 
 
As noted above, the efficiency of a trial design under a mixed model such as (1) or (9) can be 
determined by finding the linear unbiased estimator for the treatment effect that has smallest 
variance [8]. In the present case we can reasonably restrict attention to estimators that are 
linear combinations of the cluster means at each time, ?̅?∙𝑡𝑘𝑙, since each individual from the 
same cluster at a given time is assessed under the same conditions, and therefore will 
contribute equally to the treatment effect estimate. Comparing models (1) and (9) for given K 
and A we see that ?̅?∙𝑡𝑘𝑙 has the same essential structure in both, with variance given by the 
same expression in m, 𝜎2 and  under both models. The only other thing that matters to the 
variance of the treatment effect estimator is the correlation, r, between ?̅?∙𝑡1𝑘𝑙 and ?̅?∙𝑡2𝑘𝑙 for any 
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k, l, 𝑡1 ≠ 𝑡2. In other words, for given K, A, m, 𝜎
2,  and r the best linear unbiased estimator 
is the same whether we are considering model (1) or model (9).Consequently the number of 
clusters per group, K, required to achieve given statistical power for given A, m, 𝜎2,  and r 
is the same for a closed cohort cluster randomised (CC) design as for a repeated cross-section 
cluster randomised (RC) design. This equivalence has been noted previously in the special 
case of the ANCOVA design [5]. Thus from (4) we know that the total number of clusters 
required to achieve power 1 − 𝛽 at two-sided significance level α to detect a treatment effect 
𝛿∗ is 
 
𝑁CC = DeffR(𝑟CC) × DeffC(𝑚, 𝜌) ×
𝑛SI
𝑚
 
 
where 𝑟CC is the correlation [5] between ?̅?∙𝑡1𝑘𝑙 and ?̅?∙𝑡2𝑘𝑙 for any k, l, 𝑡1 ≠ 𝑡2 under model (9):
 
 
 𝑟CC =
𝑚𝜌𝜋 + (1 − 𝜌)𝜏
1 + (𝑚 − 1)𝜌
. (10) 
 
In a closed cohort design there are m participants per cluster, so the total number of 
participants required for a closed cohort cluster-randomised trial is 
 
 𝑛CC = DeffR(𝑟CC) × DeffC(𝑚, 𝜌) × 𝑛SI. (11) 
 
In the case of a stepped wedge cohort design this agrees with the formula derived by de Hoop 
and colleagues [23]. Note that for a closed cohort individually randomised (CI) design, with 
m = 1,  and  effectively zero, and r = , the total number of participants required becomes 
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𝑛CI = DeffR(𝜏) × 𝑛SI. 
 
This brings us back to familiar formulae for individually randomised trials with longitudinal 
designs [24]. For example, in an individually randomised trial with an ANCOVA design the 
total number of participants required is 
 
𝑛CI,ANCOVA = (1 − 𝜏
2) × 𝑛SI. 
 
General sample size formulae for repeated cross-section and closed cohort cluster randomised 
trials are summarised in Table 1, for easy reference. Design effects due to repeated 
assessment are tabulated by Hooper & Bourke [8] for a variety of designs and families of 
designs. 
 
4. Sample size calculation in practice 
 
4.1 Example 
 
A recent review of stepped wedge trials published between 2010 and 2014 [17] identified 11 
trials with a closed cohort design. We use one of these – an evaluation of the “Girls on the 
Go!” program to improve self-esteem in young women in Australia [25] – as an exemplar for 
our approach to sample size calculation. Clusters in this case were schools: primary schools 
were randomised to a two-step design (with assessments at baseline and after two successive 
school terms) and secondary schools to a three-step design (with assessments at baseline and 
after three successive terms). We consider the design of a three-step study. For their power 
calculation the investigators assumed 10 participants per cluster and an intracluster 
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correlation of 0.33. The primary outcome measure was the Rosenberg Self-Esteem Scale – a 
ten-item scale with each item scoring 1–4. Previous research using this scale [26] suggests an 
individual autocorrelation of around 0.7. There is less basis for the cluster autocorrelation – 
we will assume a figure of 0.9. Informed by a pilot study the investigators powered their trial 
to detect a difference of 1.5 standard deviations. This seems optimistic, and we consider 
instead the sample size to achieve 80% power at the 5% significance level to detect a mean 
difference of 2 on the Rosenberg Self-Esteem Scale, assuming a standard deviation () of 5. 
 
If this was a single cross-section, individually randomised trial, the total sample size required 
(equation 2) would be 198. For a single cross-section cluster randomised trial this would need 
to be multiplied by the design effect due to cluster randomising (equation 3), which in this 
case is 3.97, giving a total sample size of 786. Some statistical power can be reclaimed, 
however, with the longitudinal design: the correlation between two cluster sample means 
from the same cluster at different times (equation 10) is 0.8662; hence the design effect due 
to repeated assessment in a 3-step stepped wedge design (equation 7) is 0.1178. The total 
sample size required, according to our formula (equation 11), is therefore 786 × 0.1178 = 93. 
This sample size requirement would not quite be achieved with 3 clusters in each arm, but is 
more than met if we include 4 clusters per arm, or 12 clusters (120 individuals) in total 
(working back from equations (11) and (2) this gives a power of 89.3%). 
 
4.2 Sample size by simulation 
 
Simulation has been recommended as a robust alternative to approximate sample size 
formulae for stepped wedge trials [9]. For the example above we also determined the required 
sample size by simulation, using the simsam package in Stata [27], with a bespoke 
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programme to generate a data-set from our model and analyse it using mixed regression with 
restricted maximum likelihood (programme and simsam output are available in the 
Supporting Information for this article). The simsam package confirms that 4 clusters in each 
arm are needed to achieve 80% power, the estimate of power with 4 clusters per arm being 
consistent with the value obtained from the formula (99% Monte Carlo confidence interval 
88.7% - 89.5%). However, simulation also shows in this case that the Type I error rate 
exceeds 5% - a general problem affecting small-sample inference using linear mixed models 
[28]. If we could adjust the test to control this level correctly then the power would be 
reduced (corrections such as that of Kenward & Roger [28] are available but are 
computationally intensive, prohibiting large numbers of simulations for estimating power). 
 
4.3 Sensitivity of sample size to assumptions 
 
One advantage of the formula over simulation is that it allows us to relate the total required 
sample size to the sample size per cluster and the various nuisance parameters. Figure 2 
shows the overall design effect – defined here as the product of the design effect due to 
repeated assessment and the design effect due to cluster randomising – for differing values of 
the intracluster correlation, cluster autocorrelation, individual autocorrelation, and sample 
size per cluster, in the example of a 3-step closed cohort stepped wedge design. The overall 
design effect determines the required sample size for given effect size, significance and 
power. 
 
Required sample size increases with sample size per cluster. When the intracluster correlation 
is close to 1 and the cluster autocorrelation is close to 0, the required sample size is relatively 
insensitive to the intracluster correlation, cluster autocorrelation or individual autocorrelation. 
18 
 
However, for larger sample sizes per cluster, and for individual autocorrelations close to 1, 
the required sample size is particularly sensitive to the intracluster correlation when the latter 
is close to 0, and particularly sensitive to the cluster autocorrelation when the latter is close to 
1. The sensitivity to the cluster autocorrelation is also magnified at larger intracluster 
correlations (note that the intracluster correlation and cluster autocorrelation both increase 
from right to left on the graphs, to aid three-dimensional visualisation of the surfaces). 
 
In practical applications the intracluster correlation is often assumed to be small, and a 
simplified model with a cluster autocorrelation of 1 may also be assumed (Cf Hussey & 
Hughes [3]), but we would do well to be conservative and overestimate the intracluster 
correlation, and underestimate the cluster autocorrelation, given the sensitivities noted above. 
In the “Girls on the Go!” example the value assumed for the intracluster correlation is 
relatively high, so the sample size is particularly sensitive to an over-optimistic estimate of 
cluster autocorrelation. Note that in stepped wedge trials clusters are usually randomised in 
one go, at the start of the trial, so there is no possibility of modifying the sample size of a 
closed cohort part-way through using interim estimates of nuisance parameters.  
 
5. Discussion 
 
We have shown how to calculate sample size for a longitudinal cluster randomised trial with 
a repeated cross-section or closed cohort design. Randomising in clusters reduces statistical 
power, but assessing the same individuals or clusters under the control and experimental 
condition at different times can be an efficient approach to design. In choosing a design for 
any trial, investigators must weigh the competing costs associated with numbers of clusters, 
individual participants, assessments, and time-points. In this article we have only attempted 
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to consider the question of sample size: methodological problems such as how to prevent 
attrition bias in longitudinal cluster randomised trials, and how and when to obtain consent 
will need further practical investigation [7, 14]. 
 
The general formula given here for the design effect due to repeated assessment applies to 
any “complete” design [29] – that is, one where every trial arm includes an assessment at 
every time-point. Formulae for incomplete designs such as the dog-leg design can be derived 
as a separate exercise [8, 30]. Our models assume the same number of clusters in each arm, 
though the results are easily generalised to other cases by subdividing unequally sized arms 
into smaller arms which all have the same number of clusters (or simply by re-defining each 
cluster to be an arm). The most efficient distribution of clusters between arms in a complete 
stepped wedge design with a given number of steps has been described elsewhere [18, 31]. 
Our formulae are derived for continuous, normally distributed outcome measures, but can be 
extended naturally to binary outcomes by extending the definitions of intracluster correlation 
and individual autocorrelation in some appropriate way [32]. We have not considered the 
issue of variable cluster size [33].  
 
Asymptotic sample size formulae will underestimate required sample size when the number 
of clusters is small. More research is needed to determine rules of thumb for correcting the 
sample size in this case. Simulation and formulae may both turn out to have a useful role in 
planning longitudinal cluster randomised trials. More work is also needed on analysis: our 
model for closed cohort cluster randomised trials requires an analysis of cross-classified 
random effects, methods for which are available in existing statistical computing packages 
such as Stata, SAS, SPSS, R and MLwiN. In the case of designs with more than two time-
points our random effects models effectively assume an “exchangeable” correlation structure 
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within clusters and individuals over time, that is one in which the cluster or individual 
autocorrelation is the same whichever two time-points we consider. Exchangeability 
assumptions are common to most existing approaches to sample size calculation for 
longitudinal cluster randomised trials. How reasonable they are depends on the outcome 
measure, the interval between assessments, the nature of the intervention, and the nature of 
the clusters and participants. Analysis using alternative correlation structures and the 
robustness of an exchangeability approach to sample size calculation in these cases warrant 
further investigation, as do methods to combat Type I error rate inflation when the number of 
clusters is small. 
 
Whether we use a formula or simulation to determine sample size for a repeated cross-section 
or closed cohort cluster randomised trial, we need estimates of the nuisance parameters. 
These could, in principle, be estimated from time series obtained in similarly clustered 
settings with the same outcome measure, using analysis of variance to estimate variance 
components. The intracluster correlation can be estimated from a single cross-section, and 
this parameter is already widely reported for a variety of outcomes and settings. The 
individual autocorrelation of an outcome measure may be known from validation studies. The 
hardest parameter to quantify is likely to be the cluster autocorrelation. It is tempting to set 
the latter to 1, but this will lead to an over-estimate of the correlation between sample means 
from the same cluster at different times, and hence an under-estimate of the required sample 
size – that is an underpowered study. A cluster autocorrelation less than 1 allows us to model 
situations where the correlation between outcomes of two individuals sampled from the same 
cluster at different times (𝜋𝜌) is smaller than the correlation between outcomes of two 
individuals sampled from the same cluster at the same time (𝜌). This is well appreciated in 
the context of cluster randomised cross-over trials, where Giraudeau and colleagues [4] have 
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suggested assuming a cluster autocorrelation of 0.5 in the absence of other guidance, but less 
so for stepped wedge designs: of ten reports of stepped wedge trials published between 2010 
and 2014 [34], none included a component of variance between times within clusters in the 
analysis. In a repeated cross-section design some of the variation between times within a 
cluster arises because the different cross-sections come from different cohorts, and we might 
expect closed cohort studies, by definition, to have higher cluster autocorrelations than 
repeated cross-section studies. Such general rules of thumb are speculative, however. More 
work is urgently needed to evaluate and report cluster autocorrelations from real-life time 
series. Perhaps authors of longitudinal cluster randomised trials should be encouraged to 
report estimates of cluster autocorrelations, just as intracluster correlations are already 
routinely reported. 
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Figure legends 
 
Figure 1. Schematic illustration of assessment in a stepped wedge trial design with five steps. 
Assessments in each arm at each of times 0 to 5 are made under either the experimental 
treatment or the control treatment, and the trial arms differ according to the delay with which 
clusters move from the control to the experimental treatment. 
 
Figure 2. Overall design effect for a 3-step closed cohort stepped wedge trial design, 
according to the intracluster correlation (ICC), cluster autocorrelation (CAC), individual 
autocorrelation (IAC), and sample size per cluster, m. 
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Table 1. Formulae for sample size to achieve given power using repeated cross-section and 
closed cohort cluster randomised trial designs. 
 Repeated cross-section: Closed cohort: 
 at each time-point (0,1,2,…,T), m 
participants are sampled from each 
cluster 
m participants are sampled from 
each cluster at baseline and 
assessed at every time-point 
Total number 
of clusters 
DeffR(𝑟) × DeffC(𝑚, 𝜌) ×
𝑛SI
𝑚
 DeffR(𝑟) × DeffC(𝑚, 𝜌) ×
𝑛SI
𝑚
 
 
Total number 
of participants 
DeffR(𝑟) × DeffC(𝑚, 𝜌) × (𝑇 + 1)𝑛SI DeffR(𝑟) × DeffC(𝑚, 𝜌) × 𝑛SI 
Correlation, r, 
between two 
sample means 
from the same 
cluster at 
different times 
𝑚𝜌𝜋
1 + (𝑚 − 1)𝜌
 
𝑚𝜌𝜋 + (1 − 𝜌)𝜏
1 + (𝑚 − 1)𝜌
 
  
nSI is the total number of participants required for a single cross-section, individually 
randomised design;  is the intracluster correlation;  is the cluster autocorrelation;  is the 
individual autocorrelation. For definitions of the design effect due to repeated assessment, 
DeffR, and the design effect due to cluster randomising, DeffC, see the text. 
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Supporting information legend 
 
Sample size calculation by simulation in Stata, for the example given in the article: Stata code 
and output (pdf) 
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SUPPORTING INFORMATION FOR: 
Sample size calculation for stepped wedge and other longitudinal cluster randomised trials 
Richard Hooper, Steven Teerenstra, Esther de Hoop, Sandra Eldridge 
 
Sample size calculation by simulation in Stata, for the example given in the article 
 
 
1. Stata code 
 
program define s_cohortstep, rclass 
 
*** This programme generates and analyses a data-set 
*** from a closed cohort, stepped wedge trial. 
 
 version 12.0 
 syntax, SD(real) ICC(real) CAC(real) IAC(real)  /// 
  NCLUSPERGRP(integer) CLUSSIZE(integer)  /// 
  NSTEP(integer)  /// 
  TIMECOEFF(real) TREATCOEFF(real) 
 
 drop _all 
 
 scalar sdclus=`sd'*sqrt(`icc'*`cac') 
 scalar sdtime=`sd'*sqrt(`icc'*(1-`cac')) 
 scalar sdchar=`sd'*sqrt(`iac'*(1-`icc')) 
 scalar sderr=`sd'*sqrt((1-`iac')*(1-`icc')) 
 
 set obs `=`nstep'*`ncluspergrp'' 
 gen idclus=_n 
 gen group=1+mod(_n-1,`nstep') 
 gen rand_clus=rnormal(0,sdclus) 
 forvalues i=0/`nstep' { 
   gen rand_time`i'=rnormal(0,sdtime) 
 } 
 
 expand `clussize' 
 sort idclus 
 gen id=_n 
 gen rand_char=rnormal(0,sdchar) 
 
 reshape long rand_time, i(id) j(time) 
 sort idclus id time 
 
 gen treat=(time>=group) 
 gen rand_err=rnormal(0,sderr) 
 gen y=`timecoeff'*time+`treatcoeff'*treat+  /// 
  rand_clus+rand_time+rand_char+rand_err 
 
 xtmixed y i.time treat || idclus: || idclus: R.time || id:, reml 
 return scalar p=2*normal(-abs(_b[treat]/_se[treat])) 
 
end 
 
*** NB the data generation step in s_cohortstep assumes 
*** a linear effect of time for convenience, but the 
*** analysis fits time as a categorical variable. 
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*** The simsam command determines sample size by simulation. To 
*** download simsam use the command "findit simsam" and follow 
*** instructions for installation – a help file is included. 
 
*** NB as specified below simsam takes a very long time to run, 
*** because of the high precision specified for the estimates. 
*** The package can arrive at a less precise solution more 
*** quickly: e.g. try prec(0.05) instead of prec(0.005). 
 
set seed 210815 
 
simsam s_cohortstep ncluspergrp,  /// 
 assuming(sd(5) icc(0.33) cac(0.9) iac(0.7)  /// 
  clussize(10) nstep(3) timecoeff(0))  /// 
 detect(treatcoeff(2))  /// 
 null(treatcoeff(0))  /// 
 p(.8) start(2) inc(1) prec(0.005) 
 
 
2. Output 
 
------------------------------------------------------ 
iteration nclusp~p              power (99% CI) 
------------------------------------------------------ 
        1        2 ........... 0.6100 (0.4765, 0.7327) 
        2        4 ........... 0.8910 (0.8632, 0.9150) 
        3        4 ........... 0.8859 (0.8775, 0.8940) 
        4        4 ........... 0.8908 (0.8868, 0.8946) 
        5        3 ........... 0.7922 (0.7871, 0.7973) 
------------------------------------------------------ 
     null        4 ........... 0.0584 (0.0532, 0.0640) 
------------------------------------------------------ 
 
   ncluspergrp = 4 
        achieves 89.08% power (99% CI 88.68, 89.46) 
          at the 5% significance level 
    to detect 
    treatcoeff = 2 
     assuming 
            sd = 5 
           icc = 0.33 
           cac = 0.9 
           iac = 0.7 
      clussize = 10 
         nstep = 3 
     timecoeff = 0 
 
     under null:  5.84% power (99% CI  5.32,  6.40) 
 
If continuing, use prec/inc < 4.9e-02 
 
 
 
